Breeders’ Cup: Tab in Life At Ten Case Exceeds $100,000
Ron Mitchell/The Horse
August 29, 2011
A probe into Life At Ten’s Breeders’ Cup Ladies’ Classic performance has cost more than $100,000 to date.
A probe into Life At Ten’s Breeders’ Cup Ladies’ Classic performance has cost more than $100,000 to date.
A New York Supreme Court ruling regarding that state’s out-of-competition drug testing has other implications.
Thoroughbred horsemen’s groups are drawing a line in the sand when it comes to the anti-bleeding drug Salix.
A KHRC advisory panel approved a recommendation to prohibit the race day use of adjunct bleeder medications.
Gluck faculty members will speak at the 2011 Thoroughbred Pedigree, Genetics, and Performance Conference.
Researchers are working to understand the link between the myostatin gene and Thoroughbreds’ racing potential.
The New York State Racing and Wagering Board regulations on out-of-competition testing require nullification.
Several changes will be made to Aintree Racecourse’s steeplechase track prior to the 2012 Grand National.
The Jockey Club reiterated its calls for a ban of Salix but made it clear it wants medication-free racing.
BloodHorse.com’s Jason Shandler caught up with Mike Repole to get his opinion on the current Salix debate.
The AGSC will employ a program banning race-day medications in graded 2-year-old Thoroughbred stakes races.
The Old Friends Thoroughbred Retirement organization announced that it will be expanding in upstate New York.
Kentucky Derby winner Go for Gin has arrived at his new home at the Kentucky Horse Park’s Hall of Champions.
The Thoroughbred Retirement Foundation gala held Aug. 7 raised $500,000 for the care of retired Throughbreds.
The RMTC will continue to study a pilot program proposal to ban the use of Salix in 2-year-old Thoroughbreds.
The KHRC’s new laboratory choice and decision to revamp testing protocol are yielding positive results.
Stay on top of the most recent Horse Health news with
